The subgroup analysis of CHANCE and subsequent meta-analysis showed that the presence of CYP2C19 LoFA was associated with the decreased efficacy of clopidogrel in the treatment of acute ischemic stroke or transient ischemic attack (TIA) [9, 10]. Here, CYP2C19 is linked to transient ischemic attack.